StockData
MAIA Biotechnology, Inc. logo

MAIA Biotechnology, Inc. (MAIA) stock

MAIANYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 5/30
$1.30+0.05 (+4.00%)

Close on Nov 18, 2026Market cap $79.07MP/E –Yield –

MAIA Biotechnology price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

MAIA Biotechnology's price to book ratio was 3.0× on Nov 11, 2026, against 12.6× a year earlier. Over the last 2 years it ranged from 2.7× to 104.2×, with a median of 13.5×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20263.0×−7.1
2025Oct 31, 202510.2×−19.1
2024Dec 31, 202429.3×–

More MAIA Biotechnology figures

See a number that looks wrong?